# MediCare AI Roadmap

**Current status:** **Phase 27 complete — final SRS audit, clinical-validation preparation, security/privacy review, and deployment-readiness documentation completed.**  
**Next phase:** No next phase authorized; Phase 28 not started.  
**Stop condition:** Do not begin Phase 28 automatically.

| Phase | Scope | Status |
|---|---|---|
| Phase 11 | AI foundation, modular contracts, safety boundaries, governance, and tests | **Complete** |
| Phase 12 | First model implementation | **Complete — historical blocked path** |
| Phase 13 | AI requirements and dataset/algorithm specification | **Complete — historical blocked path** |
| Phase 14 | Admin module | **Complete** |
| Phase 15 | AI implementation gate | **Complete — historical blocked path** |
| Phase 16 | Capability, dataset, algorithm, evaluation, explainability, and safety finalization | **Complete** |
| Phase 17 | Approved UCI dataset acquisition, preprocessing, Logistic Regression training, comparison, evaluation, explainability, and artifact creation | **Complete — academic/development model** |
| Phase 18 | One secure Django/DRF prediction API around the fixed Phase 17 artifact | **Complete — single endpoint** |
| Phase 19 | Patient AI Insights frontend integration | **Complete as limited-access path — patient prediction remains blocked** |
| Phase 20 | Authorized doctor workflow and production-readiness hardening | **Complete — doctor form, errors, loading, safe result rendering** |
| Phase 21 | AI result integration, clinical workflow safety, and doctor experience | **Complete — informational result boundary refined** |
| Phase 22 | AI security, quality, safety, privacy, reliability, dependency, configuration, and technical production-readiness hardening | **Complete — findings mitigated; model/API/authorization preserved** |
| Phase 23 | Model-tied explainability for the existing Logistic Regression workflow | **Complete — native coefficient contributions; model/API/authorization preserved** |
| Phase 24 | Secure clinical records, metadata, doctor-only uploads, protected downloads, ownership/appointment authorization, and file-security controls | **Complete — secure clinical-file management validated** |
| Phase 25 | AI prediction reporting, minimized protected audit events, doctor-owned reports, and Admin aggregate audit summary | **Complete — reporting/auditability validated** |
| Phase 26 | SRS gap closure: doctor clinical workflow create actions for records, reports, and prescriptions; safe-DOM remediation; existing AI/security preservation | **Complete — workflow integration validated; no new AI capability** |
| Phase 27 | Final SRS gap analysis, clinical-validation preparation, model governance, security/privacy readiness, deployment readiness, and remaining-requirements closure | **Complete — production deployment and clinical validation remain externally pending** |
| Phase 28 | Future work only after explicit authorization and external dependencies | **Not started** |

## Phase 21 outcome

The existing doctor AI result experience now explicitly explains that model probability is an academic model output rather than diagnostic confidence and that the doctor remains responsible for clinical interpretation and decisions. The actual Phase 18 response fields continue to be rendered safely and transiently. The model, preprocessing, API, authorization, CSRF, rate limit, input schema, and patient restriction remain unchanged.

No patient selection or clinical-record mapping was introduced. The AI does not diagnose, prescribe, recommend treatment, update records, change appointments, create notes, create prescriptions, send notifications, trigger emergency actions, or make autonomous decisions.

## Phase 22 outcome

Phase 22 completed a targeted audit of the existing AI implementation. Confirmed issues were mitigated without changing the Phase 17 model, preprocessing, single Phase 18 endpoint, authentication, authorization, CSRF, rate limiting, patient denial, or doctor safety boundary. Production mode now fails closed unless explicit secret, debug, host, and frontend-origin settings are provided, and enables HTTPS/HSTS/security-cookie defaults. Request-size handling, inactive-doctor/method regression coverage, safe exception logging, deterministic output checks, and security documentation were added. The model remains academic/development-only and not clinically validated.

No PostgreSQL was accessed, no real patient data was used, no new AI capability or endpoint was added, and no prediction persistence was introduced.

## Phase 23 outcome

Phase 23 implemented a model-tied native Logistic Regression explanation in the existing `POST /api/ai/heart-risk/predict/` response. The explanation reuses the checksum-verified Phase 17 pipeline, maps transformed coefficients back to all 13 original features, reports signed local contributions in logit units, and includes the model intercept as a base value. The response is transient and is generated only after existing authorization and validation succeed.

The authorized doctor dashboard now renders the 13 feature contributions through safe DOM construction with textual direction labels and non-causal wording. Patient-facing AI remains denied and unchanged. The Phase 17 artifact checksum, preprocessing, endpoint route, authentication, authorization, CSRF, rate limit, input schema, privacy boundary, and clinical-safety boundary remain preserved.

## Phase 24 outcome

Phase 24 implemented secure clinical-record metadata and protected medical-file management without changing the Phase 17 model, Phase 18 endpoint, Phase 23 explainability, or established patient AI denial. Doctor-only clinical uploads use server-side extension, MIME, signature, size, and filename validation, with UUID-isolated protected storage. Patient downloads are ownership-scoped; doctor downloads are appointment-scoped or own-object scoped; unrelated doctors receive controlled 404 responses. The patient and doctor interfaces use safe DOM rendering, authenticated blob downloads, loading/empty/error states, and explicit patient-upload denial.

No real patient data, PostgreSQL, external AI, chatbot, RAG, LLM, treatment recommendation, or autonomous medical decision capability was introduced. Phase 27 performed the final current-state SRS audit, documented clinical-validation requirements, confirmed model governance, reviewed security/privacy and deployment readiness, and preserved the Phase 17 model, Phase 18 endpoint, Phase 23 explainability, Phase 24 clinical-file controls, Phase 25 reporting/auditability, Phase 26 clinical workflow, patient AI denial, and patient clinical ownership. Clinical validation and production deployment remain external dependencies. Phase 28 was not started.

## Key references

- [Phase 21 doctor AI result safety](PHASE21_DOCTOR_AI_RESULT_SAFETY.md)
- [Phase 20 authorized workflow](PHASE20_AUTHORIZED_AI_WORKFLOW.md)
- [Phase 19 patient authorization decision](PHASE19_FRONTEND_INTEGRATION.md)
- [Phase 18 API documentation](PHASE18_AI_API.md)
- [Phase 23 XAI design](PHASE23_XAI_DESIGN.md)
- [Phase 23 completion report](PHASE23_XAI_COMPLETION_REPORT.md)
- [Phase 26 completion report](MEDICARE_PHASE_26_COMPLETION_REPORT.md)
- [Phase 26 SRS traceability](MEDICARE_SRS_PHASE_26_TRACEABILITY.md)
- [Phase 27 final SRS traceability](MEDICARE_FINAL_SRS_TRACEABILITY.md)
- [Phase 27 completion audit](MEDICARE_PHASE_27_FINAL_COMPLETION_AUDIT.md)
- [Phase 27 clinical-validation readiness](PHASE27_CLINICAL_VALIDATION_READINESS.md)
- [Phase 27 deployment readiness](PHASE27_DEPLOYMENT_READINESS.md)
- [AI SRS traceability](AI_SRS_TRACEABILITY.md)
